-
Advertorial
-
FOCUS
-
Guide
-
Lifestyle
-
Tech and Vogue
-
TechandScience
-
CHTF Special
-
Nanhan
-
Futian Today
-
Hit Bravo
-
Special Report
-
Junior Journalist Program
-
World Economy
-
Opinion
-
Diversions
-
Hotels
-
Movies
-
People
-
Person of the week
-
Weekend
-
Photo Highlights
-
Currency Focus
-
Kaleidoscope
-
Tech and Science
-
News Picks
-
Yes Teens
-
Fun
-
Budding Writers
-
Campus
-
Glamour
-
News
-
Digital Paper
-
Food drink
-
Majors_Forum
-
Speak Shenzhen
-
Business_Markets
-
Shopping
-
Travel
-
Restaurants
-
Hotels
-
Investment
-
Yearend Review
-
In depth
-
Leisure Highlights
-
Sports
-
World
-
QINGDAO TODAY
-
Entertainment
-
Business
-
Markets
-
Culture
-
China
-
Shenzhen
-
Important news
在线翻译:
szdaily -> Sports
Sharapova to appeal doping ban
    2016-June-10  08:53    Shenzhen Daily

    MARIA SHARAPOVA was suspended from tennis for two years Wednesday for testing positive for meldonium at the Australian Open, and immediately responded by saying she would appeal the decision to sport’s highest court.

    The ruling by an independent three-person panel chosen by the International Tennis Federation (ITF) said Sharapova did not intend to cheat, but that she bore “sole responsibility” and “very significant fault” for the positive test.

    “While the tribunal concluded correctly that I did not intentionally violate the anti-doping rules, I cannot accept an unfairly harsh two-year suspension,” Sharapova said in a statement. “The tribunal, whose members were selected by the ITF, agreed that I did not do anything intentionally wrong, yet they seek to keep me from playing tennis for two years. I will immediately appeal the suspension portion of this ruling to CAS, the Court of Arbitration for Sport.”

    The five-time Grand Slam champion was provisionally suspended by the ITF in early March, when she announced at a news conference in Los Angeles that she failed a doping test in January.

    Sharapova said then she was not aware that the World Anti-Doping Agency had barred athletes from using meldonium, also known as mildronate, as of Jan. 1. Her lawyer, John Haggerty, said Sharapova took the substance after that date.

    In addition to testing positive at the Australian Open, the ITF said she also failed a test for meldonium in an out-of-competition control in Moscow on Feb. 2.

    Sharapova said she first was prescribed the Latvian-made drug, typically used for heart conditions, for medical reasons in 2006.

    “Today with their decision of a two-year suspension, the ITF tribunal unanimously concluded that what I did was not intentional,” Sharapova said. “The tribunal found that I did not seek treatment from my doctor for the purpose of obtaining a performance enhancing substance. The ITF spent tremendous amounts of time and resources trying to prove I intentionally violated the anti-doping rules and the tribunal concluded I did not.”

    (SD-Agencies)

深圳报业集团版权所有, 未经授权禁止复制; Copyright 2010, All Rights Reserved.
Shenzhen Daily E-mail:szdaily@szszd.com.cn